Literature DB >> 19629064

Pituitary function: Acromegaly: where are we now?

Laurence Katznelson.   

Abstract

A new consensus guideline offers an expert opinion for a multidisciplinary approach to acromegaly. How much headway have we made?

Entities:  

Mesh：

Year:  2009        PMID： 19629064     DOI： 10.1038/nrendo.2009.143

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


  7 in total

Review 1.  Guidelines for acromegaly management.

Authors:  S Melmed; F F Casanueva; F Cavagnini; P Chanson; L Frohman; A Grossman; K Ho; D Kleinberg; S Lamberts; E Laws; G Lombardi; M L Vance; K Von Werder; J Wass; A Giustina
Journal:  J Clin Endocrinol Metab       Date:  2002-09       Impact factor: 5.958

2.  Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patients.

Authors:  Annamaria Colao; Rosario Pivonello; Renata S Auriemma; Francesco Briganti; Mariano Galdiero; Fabio Tortora; Ferdinando Caranci; Sossio Cirillo; Gaetano Lombardi
Journal:  J Clin Endocrinol Metab       Date:  2006-03-14       Impact factor: 5.958

Review 3.  Drug insight: Primary medical therapy of acromegaly.

Authors:  Laurence Katznelson
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2006-02

4.  Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegaly.

Authors:  J Feenstra; W W de Herder; S M T H ten Have; A W van den Beld; R A Feelders; J A M J L Janssen; A J van der Lely
Journal:  Lancet       Date:  2005 May 7-13       Impact factor: 79.321

5.  Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index.

Authors:  Ayman M Arafat; Matthias Möhlig; Martin O Weickert; Frank H Perschel; Johannes Purschwitz; Joachim Spranger; Christian J Strasburger; Christof Schöfl; Andreas F H Pfeiffer
Journal:  J Clin Endocrinol Metab       Date:  2008-01-02       Impact factor: 5.958

6.  Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trial.

Authors:  Sven M Carlsen; Morten Lund-Johansen; Thomas Schreiner; Sylvi Aanderud; Oivind Johannesen; Johan Svartberg; John G Cooper; John K Hald; Stine L Fougner; Jens Bollerslev
Journal:  J Clin Endocrinol Metab       Date:  2008-05-20       Impact factor: 5.958

Review 7.  Guidelines for acromegaly management: an update.

Authors:  S Melmed; A Colao; A Barkan; M Molitch; A B Grossman; D Kleinberg; D Clemmons; P Chanson; E Laws; J Schlechte; M L Vance; K Ho; A Giustina
Journal:  J Clin Endocrinol Metab       Date:  2009-02-10       Impact factor: 5.958
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.